SCHEMBL7944078

SCHEMBL7944078

CCCn1c(=O)c(-c2nccs2)nc2c(N)ccnc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 3/20 0.42
ADORA1 P30542 9/20 0.40
ADORA2A P29274 8/20 0.40
ADORA3 P0DMS8 3/20 0.40
HSF1 Q00613 1/20 0.39
ADORA2B P29275 5/20 0.36
HSP90AA1 P07900 1/20 0.35
ECE1 P42892 1/20 0.33
MEN1 O00255 2/20 0.33
USP2 O75604 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
MAPK1 P28482 2/20 0.33
CASP1 P29466 2/20 0.33
CASP7 P55210 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7944114 0.93 PDE4B (0.48) PDE4BADORA1ADORA2AADORA3HSF1
SCHEMBL7947184 0.88 CYP1A2 (0.45) MEN1USP2CYP1A2CYP3A4CYP2D6
SCHEMBL3218027 0.87 PDE4B (0.39) PDE4BADORA1ADORA2AADORA3HSF1
SCHEMBL7938177 0.86 PDE4B (0.41) PDE4BADORA2AADORA2BMEN1USP2
SCHEMBL7947387 0.83 ADORA1 (0.36) PDE4BADORA1ADORA2AADORA3ADORA2B
SCHEMBL7947925 0.82 ADORA1 (0.36) PDE4BADORA1ADORA2AADORA3ADORA2B
SCHEMBL7944574 0.82 HSF1 (0.36) ADORA1ADORA2AADORA3HSF1ADORA2B
SCHEMBL7943995 0.81 HSF1 (0.36) ADORA1ADORA2AADORA3HSF1MEN1
SCHEMBL7937747 0.80 HSF1 (0.35) ADORA1ADORA2AADORA3HSF1MEN1
SCHEMBL7937752 0.76 ADORA2A (0.39) PDE4BADORA1ADORA2AADORA3HSF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010008775-A1 AMINOPYRIDOPYRAZINONE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES LIGAND PHARMACEUTICALS INC. (US) 2010-01-21 WO disclosed